The Impact in Japan of Regulatory Action on Prescribing of Dopamine Receptor Agonists: Analysis of a Claims Database between 2005 and 2008

Author： Ooba Nobuhiro  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.4, 2011-04, pp. : 329-338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of Dopamine Agonists in the Treatment of Parkinson's Disease in Japan

By Shimbo T.  

PharmacoEconomics, Vol. 19, Iss. 8, 2001-01 ,pp. : 875-886

Adis International

Access to resources Recommend Favorite

Dopamine receptor agonists for treating prolactinomas

By Colao Annamaria   Somma Carolina di   Lombardi Gaetano   Pivonello Rosario   Sarno Antonella di  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 787-800

Informa Healthcare

Access to resources Recommend Favorite

Risk of Hospitalization for Hip Fracture and Pneumonia Associated with Antipsychotic Prescribing in the Elderly: A Self-Controlled Case-Series Analysis in an Australian Health Care Claims Database

By Pratt Nicole   Roughead Elizabeth E.  

Drug Safety, Vol. 34, Iss. 7, 2011-07 ,pp. : 567-575

Adis International

Access to resources Recommend Favorite

Dopamine receptor agonists linked with impulse control disorders

By  

Reactions Weekly, Vol. 1, Iss. 1117, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Dopamine D1 receptor agonists as antiparkinson drugs

By Mailman R.B.   Nichols D.E.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 7, 1998-07 ,pp. : 255-256

Elsevier

Access to resources Recommend Favorite